True gloveless is the ultimate challenge that we are addressing to realise our vision of aseptic processing. It is more about ensuring 100% automation / 0% human intervention than simply removing gloves. Our target is to bring INJECTA as close as possible to the gloveless concept through a step-by-step evolution of technologies, involving our R&D departments and influencing key market players to adopt solutions that will ultimately enable truly gloveless aseptic processing.

So far, we’ve taken the true gloveless concept a step closer to reality, implementing fully automated assembly of the stopper feeding unit and of the filling group. This has been achieved by designing the groups and necessary components so that their assembly is fully managed by robots after entering the initial processing area of INJECTA as autoclaved parts inside a stainless steel canister.

Thanks to our pioneering use of robotic technologies, this step of the process has been made truly gloveless.

In the future accomplishing true gloveless processing will depend on our ability to exploit existing technologies and drive innovation towards the ultimate evolution of aseptic processing in an environment in which human intervention is absent. However, achieving such evolution will also hinge on the willingness of other market players to adopt cutting-edge solutions and adapt them to come in line with our vision.

Today, we still count on human intervention to pick up and assemble single-use needles. However, the future has been captured in a solution we designed in-house to make this step an automatic, gloveless operation managed by robots. Designing our own single-use needles kit, we have been able to envisage the answer we expect from the next evolution.

Nonetheless we depend on the manufacturers of single-use kits to join us as we strive to make true gloveless processing a reality for tomorrow’s pharmaceutical industry.